#emd serono

Rupitasertib CAS 1379545-95-5 MF C21H19ClF3N5O 449.9 g/mol 4-({(1S)-2-(azetidin-1-yl)-1-[4-chloro-3-(trifluoromethyl)phenyl]ethyl}amino)quinazoline-8-carboxamide 4-[[(1S)-2-(azetidin-1-yl)-1-[4-chloro-3-(trifluoromethyl)phenyl]ethyl]amino]quinazoline-8-carboxamideserine/ threonine kinase inhibitor, antineoplastic, EMD SERONO, Gastric cancer; HER2 positive breast cancer; Solid tumours, M2698…

Cladribine

クラドリビン

Leustatin クラドリビン

RWJ 26251 / RWJ-26251

Molecular FormulaC10H12ClN5O3

Average mass285.687 Da

2-chloro-6-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)purine 2-Chlorodeoxyadenosine 4291-63-8 [RN] 6997 adenosine, 2-chloro-2′-deoxy- [ACD/Index Name] AU7357560 CDA (2R,3S,5R)-5-(6-Amino-2-chlor-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-olLeustatin (Trade name) Litak (Trade…

FDA approves new oral treatment for multiple sclerosis, Mavenclad (cladribine)

FDA approves new oral treatment for multiple sclerosis, Mavenclad (cladribine) The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease and active secondary progressive disease. Mavenclad is not recommended for MS patients with clinically isolated syndrome. Because of…

EMD Serono's hiring big to staff up their new research facility in Billerica, Massachusetts--a stone's throw from Boston.  The hiring effort started last year, now that facility construction has been completed, the company's got the capacity to hire another 100 employees. Take a tour here. EMD Serono is a subsidiary of Merck.